Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of TQH2722 in Chronic Sinusitis With or Without Nasal Polyps
NCT06439381Phase 2Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2024
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 2 trial of TQH2722 in chronic rhinosinusitis (CRS), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jul 2024; status: completed.
02
Drugs
TQH2722
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on NCT06439381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06439381.